The investment seeks to achieve long-term growth of capital and income by investing primarily in a diversified portfolio of equity securities of larger, well-established companies... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GAFFX | 82.92 | 0.81 | +0.99% |
American Funds Growth Fund of Amer F3 | |||
DCEMX | 13.94 | N/A | N/A |
Dunham Emerging Markets Stock C | |||
IIIIX | 13.08 | N/A | N/A |
Voya International Index Port I | |||
WFTCX | 5.16 | N/A | N/A |
Allspring Innovation Fund - Class C | |||
JFNIX | 66.23 | N/A | N/A |
Janus Henderson Global Life Sciences I |
A.I.dvisor indicates that over the last year, MMNBX has been loosely correlated with RMFEX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MMNBX jumps, then RMFEX could also see price increases.
Ticker / NAME | Correlation To MMNBX | 1D Price Change % | ||
---|---|---|---|---|
MMNBX | 100% | N/A | ||
RMFEX - MMNBX | 41% Loosely correlated | +0.64% | ||
RMEBX - MMNBX | 41% Loosely correlated | +0.64% | ||
RMFCX - MMNBX | 41% Loosely correlated | +0.66% | ||
VIVAX - MMNBX | 34% Loosely correlated | N/A | ||
VIVIX - MMNBX | 34% Loosely correlated | N/A | ||
More |